These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8146211)

  • 1. Amelioration by aniracetam of abnormalities as revealed in choice reaction performance and shuttle behavior.
    Himori N; Mishima K
    Pharmacol Biochem Behav; 1994 Feb; 47(2):219-25. PubMed ID: 8146211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aniracetam restores motivation reduced by satiation in a choice reaction task in aged rats.
    Nakamura K; Kurasawa M
    Pharmacol Biochem Behav; 2001 Jan; 68(1):65-9. PubMed ID: 11274709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between oxiracetam, aniracetam and scopolamine on behavior and brain acetylcholine.
    Spignoli G; Pepeu G
    Pharmacol Biochem Behav; 1987 Jul; 27(3):491-5. PubMed ID: 3659072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolongation of latencies for passive avoidance responses in rats treated with aniracetam or piracetam.
    Yamada K; Inoue T; Tanaka M; Furukawa T
    Pharmacol Biochem Behav; 1985 Apr; 22(4):645-8. PubMed ID: 3991773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of BY-1949 on three kinds of experimental amnesia in rodents].
    Tanabe S; Ikeda Y; Sugawa M; Iwasaki T
    Yakubutsu Seishin Kodo; 1990 Jun; 10(2):297-305. PubMed ID: 2251878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant-like effects of aniracetam in aged rats and its mode of action.
    Nakamura K; Tanaka Y
    Psychopharmacology (Berl); 2001 Nov; 158(2):205-12. PubMed ID: 11702095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impulsivity and AMPA receptors: aniracetam ameliorates impulsive behavior induced by a blockade of AMPA receptors in rats.
    Nakamura K; Kurasawa M; Shirane M
    Brain Res; 2000 Apr; 862(1-2):266-9. PubMed ID: 10799697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aniracetam, a pyrrolidinone-type cognition enhancer, attenuates the hydroxyl free radical formation in the brain of mice with brain ischaemia.
    Himori N; Suzuki T; Ueno K
    J Pharm Pharmacol; 1995 Mar; 47(3):253-8. PubMed ID: 7602492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of scopolamine and nootropic drugs on rewarded alternation in a T-maze.
    Bartolini L; Risaliti R; Pepeu G
    Pharmacol Biochem Behav; 1992 Dec; 43(4):1161-4. PubMed ID: 1475299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aniracetam improves radial maze performance in rats.
    Martin JR; Cumin R; Aschwanden W; Moreau JL; Jenck F; Haefely WE
    Neuroreport; 1992 Jan; 3(1):81-3. PubMed ID: 1611039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of apomorphine on operant behavior in rats under normoxic and hypoxic conditions.
    Sakurai I; Sato T; Yoshioka T; Nakamura A
    Aviat Space Environ Med; 1991 Nov; 62(11):1050-3. PubMed ID: 1741718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hyperventilation-induced ischaemia model in human neuropharmacology: neurophysiological and psychometric studies of aniracetam and 3-OH aniracetam.
    Kraaier V; van Huffelen AC; Wieneke GH
    Eur J Clin Pharmacol; 1989; 36(6):605-11. PubMed ID: 2776818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apomorphine-induced hypoattention in rats and reversal of the choice performance impairment by aniracetam.
    Nakamura K; Kurasawa M; Tanaka Y
    Eur J Pharmacol; 1998 Jan; 342(2-3):127-38. PubMed ID: 9548378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vinpocetine: nootropic effects on scopolamine-induced and hypoxia-induced retrieval deficits of a step-through passive avoidance response in rats.
    DeNoble VJ; Repetti SJ; Gelpke LW; Wood LM; Keim KL
    Pharmacol Biochem Behav; 1986 Apr; 24(4):1123-8. PubMed ID: 3714768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of aniracetam on phosphatidylinositol transfer protein alpha in cytosolic and plasma membrane fractions of astrocytes subjected to simulated ischemia in vitro.
    Gabryel B; Chalimoniuk M; Małecki A; Strosznajder J
    Pharmacol Rep; 2005; 57(5):664-9. PubMed ID: 16227651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erk1/2 and Akt kinases are involved in the protective effect of aniracetam in astrocytes subjected to simulated ischemia in vitro.
    Gabryel B; Pudelko A; Malecki A
    Eur J Pharmacol; 2004 Jun; 494(2-3):111-20. PubMed ID: 15212964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug dependence test on a cerebral insufficiency improver, aniracetam].
    Kuwahara A; Kubota A; Hakkei M; Nakamura K
    Nihon Yakurigaku Zasshi; 1987 Jan; 89(1):33-46. PubMed ID: 3570103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piracetam and aniracetam antagonism of centrally active drug-induced antinociception.
    Galeotti N; Ghelardini C; Bartolini A
    Pharmacol Biochem Behav; 1996 Apr; 53(4):943-50. PubMed ID: 8801601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facilitation of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor transmission in the suprachiasmatic nucleus by aniracetam enhances photic responses of the biological clock in rodents.
    Moriya T; Ikeda M; Teshima K; Hara R; Kuriyama K; Yoshioka T; Allen CN; Shibata S
    J Neurochem; 2003 May; 85(4):978-87. PubMed ID: 12716429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 7-Chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine S,S-dioxide (IDRA 21), a congener of aniracetam, potently abates pharmacologically induced cognitive impairments in patas monkeys.
    Thompson DM; Guidotti A; DiBella M; Costa E
    Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7667-71. PubMed ID: 7644474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.